• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Screening for Fabry disease in patients with left ventricular noncompaction.

作者信息

Azevedo Olga, Marques Nuno, Craveiro Nuno, Pereira Ana Rita, Antunes Hugo, Reis Liliana, Guerreiro Rui Azevedo, Pontes Dos Santos Rui, Miltenberger-Miltenyi Gabriel, Sousa Nuno, Cunha Damião

机构信息

Cardiology Department, Reference Center on Lysosomal Storage Disorders, Hospital Senhora da Oliveira, Guimarães, Portugal; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3Bs PT Government Associate Laboratory, Braga/Guimarães, Portugal.

Cardiology Department, Centro Hospitalar Universitário do Algarve, Faro, Portugal; Algarve Biomedical Center, Faro, Portugal; Biomedical Science and Medicine Department, Algarve University, Faro, Portugal.

出版信息

Rev Port Cardiol (Engl Ed). 2019 Oct;38(10):709-716. doi: 10.1016/j.repc.2019.02.014. Epub 2020 Jan 1.

DOI:10.1016/j.repc.2019.02.014
PMID:31901299
Abstract

INTRODUCTION AND AIM

It is unclear whether left ventricular noncompaction (LVNC) is a distinct cardiomyopathy or a morphologic manifestation of different cardiomyopathies. We previously reported a case of LVNC in a Fabry disease (FD) patient, but it remains to be clarified whether LVNC is a cardiac manifestation of FD, a coincidental finding or an overdiagnosis, which has major therapeutic implications. This study aims to determine the prevalence of FD among patients with LVNC.

METHODS

We performed a retrospective study including all patients diagnosed with LVNC in eight hospital centers. Diagnosis of LVNC was based on at least one echocardiographic or cardiac magnetic resonance criterion. FD screening was performed by combined enzyme and genetic testing.

RESULTS

The study included 78 patients diagnosed with LVNC based on the Jenni (84.6%), Stöllberger (46.2%), Chin (21.8%), Petersen (83.8%) and Jacquier (16.2%) criteria. Left ventricular systolic dysfunction was present in 48.7%. Heart failure was found in 60.3%, ventricular dysrhythmias in 21.6% and embolic events in 11.5%. FD screening found no additional cases among patients with LVNC, besides the previously described case.

CONCLUSION

No additional FD cases were found among patients with LVNC, which argues against the hypothesis that LVNC is a cardiac manifestation of FD.

摘要

相似文献

1
Screening for Fabry disease in patients with left ventricular noncompaction.
Rev Port Cardiol (Engl Ed). 2019 Oct;38(10):709-716. doi: 10.1016/j.repc.2019.02.014. Epub 2020 Jan 1.
2
Left ventricular noncompaction in a patient with fabry disease: overdiagnosis, morphological manifestation of fabry disease or two unrelated rare conditions in the same patient?法布里病患者的左心室心肌致密化不全:过度诊断、法布里病的形态学表现还是同一患者中两种不相关的罕见病症?
Cardiology. 2011;119(3):155-9. doi: 10.1159/000330924. Epub 2011 Sep 23.
3
Prevalence and Prognostic Significance of Left Ventricular Noncompaction in Patients Referred for Cardiac Magnetic Resonance Imaging.接受心脏磁共振成像检查的患者左心室心肌致密化不全的患病率及预后意义
Circ Cardiovasc Imaging. 2017 Sep;10(9). doi: 10.1161/CIRCIMAGING.117.006174.
4
Association Between Left Ventricular Noncompaction and Vigorous Physical Activity.左心室致密化不全与剧烈体力活动的关系。
J Am Coll Cardiol. 2020 Oct 13;76(15):1723-1733. doi: 10.1016/j.jacc.2020.08.030.
5
Quantification of left ventricular trabeculae using fractal analysis.运用分形分析对左心室小梁进行量化。
J Cardiovasc Magn Reson. 2013 May 10;15(1):36. doi: 10.1186/1532-429X-15-36.
6
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction.左心室心肌致密化不全患者中晚期钆增强和整体收缩功能障碍的预后作用的荟萃分析。
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2141-2151. doi: 10.1016/j.jcmg.2018.12.029. Epub 2019 Mar 13.
7
Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy?左心室心肌致密化不全:解剖学表型还是独特的心肌病?
J Am Coll Cardiol. 2016 Nov 15;68(20):2157-2165. doi: 10.1016/j.jacc.2016.08.054.
8
Histopathological evidence of Fabry disease in a female patient with left ventricular noncompaction.一名患有左心室心肌致密化不全的女性患者的法布里病组织病理学证据。
Rev Port Cardiol. 2014 Sep;33(9):565.e1-6. doi: 10.1016/j.repc.2014.02.021. Epub 2014 Sep 20.
9
Left-ventricular non-compaction-comparison between different techniques of quantification of trabeculations: Should the diagnostic thresholds be modified?左心室心肌致密化不全——不同心肌小梁量化技术比较:是否需要修改诊断阈值?
Arch Cardiovasc Dis. 2020 May;113(5):321-331. doi: 10.1016/j.acvd.2020.01.004. Epub 2020 Apr 2.
10
Comparison of systolic and diastolic criteria for isolated LV noncompaction in CMR.比较 MRI 中孤立性左心室肥厚伴舒张功能不全的收缩和舒张标准。
JACC Cardiovasc Imaging. 2013 Sep;6(9):931-40. doi: 10.1016/j.jcmg.2013.01.014. Epub 2013 Jun 13.

引用本文的文献

1
Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women.安德森-法布里心肌病的性别差异:女性的临床、遗传和影像学分析。
Genes (Basel). 2023 Sep 15;14(9):1804. doi: 10.3390/genes14091804.
2
High-Risk Screening for Fabry Disease: A Nationwide Study in Japan and Literature Review.法布里病的高危筛查:日本全国性研究及文献综述
Diagnostics (Basel). 2021 Sep 27;11(10):1779. doi: 10.3390/diagnostics11101779.